Skip to content

688331.SH

RemeGen Co., Ltd.

SSE · Healthcare · Biotechnology · CN

CNY 116.42
−7.24%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue8.0B3.3B1.7B1.1B772.1M
Cost of Revenue535.1M413.5M337.2M244.4M272.0M
Gross Profit7.4B2.8B1.4B838.6M500.1M
Operating Expenses
R&D Expense961.4M1.2B1.5B1.3B982.1M
SG&A Expense443.0M
General & Admin Expense298.4M364.3M316.7M304.2M266.3M
Selling & Marketing Expense860.5M1.1B948.8M775.2M440.7M
Other Expenses4.5M
Total Operating Expenses2.6B2.8B2.9B2.4B1.6B
Cost and Expenses3.1B3.2B3.2B2.6B1.9B
Operating Income (EBIT)5.9B722.6M(1.5B)(1.5B)(995.2M)
Non-Operating
Interest Income9.6M
Interest Expense4.3M
Net Interest Income5.3M
Other Non-Op Income/Expense(52.0M)
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)5.8B710.4M(1.5B)(1.5B)(998.8M)
Income Tax Expense590.9K748.7K
Bottom Line
Net Income5.8B709.6M(1.5B)(1.5B)(998.8M)
Earnings from Cont. Ops5.8B709.6M(1.5B)(1.5B)(998.8M)
Earnings from Discont. Ops
Bottom Line Net Income5.8B709.6M(1.5B)(1.5B)(998.8M)
Per Share
Basic EPSCN¥10.40CN¥1.29(CN¥2.73)(CN¥2.80)(CN¥1.88)
Diluted EPSCN¥10.36CN¥1.29(CN¥2.73)(CN¥2.80)(CN¥1.88)
Revenue Per ShareCN¥14.25CN¥5.91CN¥3.19CN¥2.01CN¥1.45
Shares
Basic Shares Outstanding560.2M550.1M537.9M539.7M531.3M
Diluted Shares Outstanding562.6M550.1M537.9M539.7M531.3M
Profitability Metrics
EBITDA4.4B985.5M(1.2B)(1.3B)(870.0M)
D&A76.8M262.9M241.6M179.3M125.2M
EBIT4.4B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026